Assenagon Asset Management S.A. Lowers Stock Holdings in Revvity Inc. (NYSE:RVTY)

Assenagon Asset Management S.A. decreased its holdings in shares of Revvity Inc. (NYSE:RVTY - Free Report) by 73.0% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 5,300 shares of the company's stock after selling 14,359 shares during the period. Assenagon Asset Management S.A.'s holdings in Revvity were worth $561,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Nissay Asset Management Corp Japan ADV increased its stake in shares of Revvity by 0.6% during the fourth quarter. Nissay Asset Management Corp Japan ADV now owns 15,023 shares of the company's stock valued at $1,682,000 after purchasing an additional 91 shares in the last quarter. Quarry LP grew its holdings in shares of Revvity by 45.7% during the fourth quarter. Quarry LP now owns 303 shares of the company's stock valued at $34,000 after buying an additional 95 shares during the last quarter. Signaturefd LLC grew its holdings in shares of Revvity by 6.8% during the fourth quarter. Signaturefd LLC now owns 1,668 shares of the company's stock valued at $186,000 after buying an additional 106 shares during the last quarter. RDA Financial Network grew its holdings in shares of Revvity by 3.6% during the first quarter. RDA Financial Network now owns 3,331 shares of the company's stock valued at $352,000 after buying an additional 115 shares during the last quarter. Finally, EverSource Wealth Advisors LLC grew its holdings in shares of Revvity by 33.5% during the fourth quarter. EverSource Wealth Advisors LLC now owns 522 shares of the company's stock valued at $58,000 after buying an additional 131 shares during the last quarter. Institutional investors own 86.65% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. JPMorgan Chase & Co. cut their price target on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating on the stock in a report on Tuesday, April 29th. UBS Group upgraded shares of Revvity from a "neutral" rating to a "buy" rating and cut their price target for the company from $145.00 to $115.00 in a report on Thursday, May 1st. The Goldman Sachs Group cut their price target on shares of Revvity from $140.00 to $125.00 and set a "buy" rating on the stock in a report on Tuesday, April 29th. Wells Fargo & Company cut their price target on shares of Revvity from $130.00 to $102.00 and set an "equal weight" rating on the stock in a report on Thursday, April 17th. Finally, Raymond James Financial reiterated an "outperform" rating and set a $120.00 price target (down previously from $145.00) on shares of Revvity in a report on Tuesday, April 29th. Five analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $125.64.

Revvity Trading Up 0.0%

Shares of RVTY stock traded up $0.02 during trading hours on Monday, reaching $95.01. 809,730 shares of the stock were exchanged, compared to its average volume of 965,247. Revvity Inc. has a 12-month low of $87.70 and a 12-month high of $129.50. The company has a current ratio of 3.58, a quick ratio of 2.99 and a debt-to-equity ratio of 0.41. The company's 50-day moving average price is $93.05 and its 200-day moving average price is $106.00. The firm has a market capitalization of $11.20 billion, a price-to-earnings ratio of 40.43, a price-to-earnings-growth ratio of 2.32 and a beta of 0.97.

Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings results on Monday, April 28th. The company reported $1.01 EPS for the quarter, topping analysts' consensus estimates of $0.96 by $0.05. Revvity had a net margin of 10.35% and a return on equity of 7.73%. The firm had revenue of $664.76 million during the quarter, compared to analysts' expectations of $662.30 million. During the same period in the previous year, the company earned $0.98 EPS. The firm's revenue for the quarter was up 2.3% compared to the same quarter last year. As a group, equities analysts anticipate that Revvity Inc. will post 4.94 earnings per share for the current year.

Revvity Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 8th. Investors of record on Friday, July 18th will be paid a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, July 18th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.29%. Revvity's dividend payout ratio is presently 11.91%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.